Prashant S. Kharkar

Three-Dimensional Quantitative Structure−Activity Relationship of 1,4-Dihydropyridines As Antitubercular Agents

Prashant S. Kharkar, Bhavik Desai, Harsukh Gaveria et al. · Journal of Medicinal Chemistry · 2002 · 113 citations

Banana Peel Waste: An Emerging Cellulosic Material to Extract Nanocrystalline Cellulose

Shweta Mishra, Bala Prabhakar, Prashant S. Kharkar et al. · ACS Omega · 2022 · 82 citations · Full text

Interaction of cocaine‐, benztropine‐, and GBR12909‐like compounds with wild‐type and mutant human dopamine transporters: molecular features that differentially determine antagonist‐binding properties

Kyle C. Schmitt, Juan Zhen, Prashant S. Kharkar et al. · Journal of Neurochemistry · 2008 · 74 citations · Full text

Phospholipid complex-loaded self-assembled phytosomal soft nanoparticles: evidence of enhanced solubility, dissolution rate, ex vivo permeability, oral bioavailability, and antioxidant potential of mangiferin

Darshan R. Telange, Nazish K. Sohail, Atul T. Hemke et al. · Drug Delivery and Translational Research · 2020 · 66 citations

Nanoparticles, Nanomedicine, Engineering +8

Development of (<i>S</i>)-<i>N</i>⁶-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-<i>N</i>⁶-propyl-4,5,6,7-tetrahydrobenzo[<i>d</i>]-thiazole-2,6-diamine and Its Analogue as a D3 Receptor Preferring Agonist: Potent in Vivo Activity in Parkinson’s Disease Animal Models

Balaram Ghosh, Tamara Antonio, Juan Zhen et al. · Journal of Medicinal Chemistry · 2009 · 62 citations · Full text